Here’s how I’d invest £200 per month in an ISA starting right now

Want to get involved in the market recovery? Here’s how I’d invest in growth and income shares in an ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A lot of investment advice makes the point that it is important to invest regularly and to start as early as possible. This is why I’d be keen to invest a sum like £200 in an ISA right now. The market is also recovering from the March crash and this situation could well continue, enabling investors to make gains in the short-term. 

Investing in an ISA

When investing a relatively small amount of money I’d want it to grow over time. One of the best ways to achieve growth is to collect dividends and the reinvest them in more shares. This creates a nice cycle where you have ever more shares paying ever more income and hopefully growing in value as well.

The double engine of share price growth with dividend income can really boost an investor’s finances. But it’s very important to take the leap and get started. Doing so at a time then market is growing could give a confidence boost that’s essential for long-term investing.

So I’d use my £200 to invest in FTSE 100 shares that are still paying a dividend and likely to keep doing so. I’d also want the company to have decent growth prospects and not be in a declining industry like tobacco.

Shares for an ISA

There are two shares that come to mind and meet these criteria. One is the pharmaceutical giant GlaxoSmithKline (LSE: GSK). It has held its dividend flat, which is a very fortunate decision in retrospect. It has done this to invest in R&D which will be vital to developing new blockbuster drugs.

It’s also reorganising and selling off the consumer part of the business. This will make it a closer rival to AstraZeneca, which has done extremely well in recent years. It recently became the most valuable FTSE 100 company.

Even though the dividend has been held flat for several years, the shares still have a 4.8% dividend yield. I think investing in GlaxoSmithKline is a good way to get defensive shares. This kind of share should rise regardless of what happens to the economy.

Shares in Legal & General (LSE:LGEN) are both cheaper and high yielding than GSK’s. The company has become a force to be reckoned with in the pensions industry – a definite growth market given the greying population.

Legal & General has committed to keep paying its dividend, despite pressure from the regulator and many of its rivals, including Aviva, suspending theirs.

The group has been shown strong growth in revenue and operating profits. Even so, the shares have been hit during the market sell-off. This is because it is seen as a financial stock, and financial stocks are generally at greater risk in a falling economy.

However, I’m not sure that the economy has a big effect on Legal & General. Its shares now yield over 8% and have a price-to-earnings of only 6. This is why I think the shares are ideal to invest in right now.

Andy Ross owns shares in Legal & General and AstraZeneca. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Workers at Whiting refinery, US
Investing Articles

Why is everyone selling BP shares?

BP shares have been some of the most sold in the last week. What's going on here? And could this…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Is this market correction a once-in-a-decade chance to buy ultra-high-yield income stocks?

As share prices fall, dividend yields rise. The FTSE 100 is full of top income stocks and Harvey Jones says…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Down 25% in a month! Are these the 3 best stocks to buy in today’s correction… or the worst?

Harvey Jones examines whether the best stocks to buy today can all be found in the FTSE 100 sector that…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

This FTSE small-cap stock can surge 105%, says one broker

Ben McPoland highlights a FTSE small-cap share that's trading cheaply and offering a dividend for the first time since 2019.

Read more »

A mature adult sitting by a fireplace in a living room at home. She is wearing a yellow cardigan and spectacles.
Investing Articles

£10,000 invested in ultra-high yield Legal & General shares on 5 April last year is now worth…

Investors typically buy Legal & General shares for the dividend income, as they now yield more than 8.5%. But will…

Read more »

Modern apartments on both side of river Irwell passing through Manchester city centre, UK.
Investing Articles

With an empty ISA today, how long would it take to aim for a million?

Is it realistic to aim for a million with an empty ISA? Our writer turns from fantasy to facts to…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

What on earth’s going on with the Helium One share price?

The Helium One share price rally has stalled. Our writer reflects on the reasons and asks whether now could be…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Getting started with investing? Here are 3 UK stocks to take a look at

The next time the stock market opens, it will be the new financial year. And Stephen Wright has three UK…

Read more »